- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02140307
Relaxation-Response-based Mental Health Promotion - Open and Calm 2013 (RR-MHP OC13)
Study of Potential Health Effects of a Relaxation-response-based Mental Health Promotion Course (RR-MHP) and the Possibilities for Its Applications in the Danish Public Health Sector
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Copenhagen OE, Denmark, 2100
- Neurobiology Research Unit, dep. 9201, Copenhagen University Hospital (Rigshospitalet)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria
- Experience of stress, defined as a Cohen's perceived stress scale score > 12.
- Speaks and reads Danish fluently.
- Ability to use the internet to complete questionnaires.
- Participation in face-to-face study information meeting.
- Signed agreement to the study conditions and informed consent form
Exclusion Criteria
- Other current treatment (psychological, medical or other) for stress, depression, anxiety, phobias, traumas or other psychological problems.
- Other current treatment for bodily illnesses, such as pain, migraine, cancer.
- More than one diagnose with psychiatric disease (e.g. anxiety, depression) within the past 3 years.
- Body-Mass Index > 30.
- Major Depression Inventory score > 25 at inclusion interview.
- Physical handicaps affecting life stress or quality of life chronically.
- Drug use (> 50 times hash during the past two years; max 20 times harder drugs, max 2 times per month since the 18th birthday on average; no periods > 3 years where the use of drugs exceeded two times per month).
- Alcohol use > 21 drinks/week for men, and > 14 drinks/week for women and AUDIT-scores (a scale of alcohol-related problems) >20.
- Serious head trauma.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Meditation training, group format
The course Relaxation Response-based Mental Health Promotion (publicly referred to as "Open and Calm") is given in group format. The intervention entails 9 courses (1 per week of 2.5 hrs), a course book (120 pages), audio support (6 guided meditative practices), access to a webpage with additional information, and the possibility of two personal sessions with the intervention instructor (a certified psychologist). |
The Open and Calm intervention is based on a standardized 9-week program.
Week 1 uses a simple mantra-based meditation.
Week 2 and 5 uses focus on the body.
Week 3 and 6 uses focus on thoughts and emotions.
Week 4 and 7 uses focus on social relationships.
Weeks 8 and 9 were entitled "The focus you feel like", where participants chose their own focus (e.g. two weeks of bodily focus if that was most relevant for a person, while another might chose 1 week focusing on emotions and another focusing on a social relationship).
Other Names:
|
|
Active Comparator: Meditation training, individual format
The course Relaxation Response-based Mental Health Promotion ("Open and Calm") is given by the same instructor as for group formats using precisely the same material and methods, but in about 6-9 (as to each persons' individual needs and preferences) face-to-face meetings.
|
The Open and Calm intervention is based on a standardized 9-week program.
Week 1 uses a simple mantra-based meditation.
Week 2 and 5 uses focus on the body.
Week 3 and 6 uses focus on thoughts and emotions.
Week 4 and 7 uses focus on social relationships.
Weeks 8 and 9 were entitled "The focus you feel like", where participants chose their own focus (e.g. two weeks of bodily focus if that was most relevant for a person, while another might chose 1 week focusing on emotions and another focusing on a social relationship).
Other Names:
|
|
No Intervention: Wait-list control
This arm is an inactive wait-list control.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in scores on Perceived Stress on Cohen's Perceived Stress Scale
Time Frame: From baseline to post-treatment (9 weeks later) and to 3-month follow-up
|
The investigators expect a decrease in perceived stress of significantly larger magnitude in interventional groups than in waitlist controls across the three time points
|
From baseline to post-treatment (9 weeks later) and to 3-month follow-up
|
|
Cortisol secretion as measured by the cortisol awakening response
Time Frame: From baseline to post-treatment (after 9 weeks)
|
The investigators expect a significant reduction of cortisol secretion in intervention groups and larger than in wait-list controls. Specifically, the investigators analyze the Area Under Curve with respect to Ground (total cortisol output) after awakening. Cortisol was only collected for 2/3 data waves (N = 48) due to logistics. COMMENT: The investigators have two primary outcomes, but both are measures of stress levels. The investigators expect to see both hormonal and perceived stress improvements. |
From baseline to post-treatment (after 9 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Pittsburgh Sleep Quality Index (PSQI)
Time Frame: From baseline to post-treatment (9 weeks later) and to 3-month follow-up
|
The investigators expect a larger improvement of sleep quality in the intervention groups than in the wait-list controls over the course of the three time points
|
From baseline to post-treatment (9 weeks later) and to 3-month follow-up
|
|
Change in Quality of Life on the WHO-5 scale
Time Frame: From baseline to post-treatment (9 weeks later) and to 3-month follow-up
|
The investigators expect a larger improvement in perceived quality of life in intervention groups compared to wait-list controls over the course of the three time points
|
From baseline to post-treatment (9 weeks later) and to 3-month follow-up
|
|
Change in Short-Form Health Survey-36
Time Frame: From baseline to post-treatment (9 weeks later) and to 3-month follow-up
|
The investigators expect a significantly larger improvement in quality of life (SF-36-Mental Component Summary Score and SF-36 Physical Component Summary Score) in intervention groups compared to wait-list controls over the course of the three time points.
|
From baseline to post-treatment (9 weeks later) and to 3-month follow-up
|
|
Change in Major Depression Inventory
Time Frame: From baseline to post-treatment (9 weeks later) and to 3-month follow-up
|
The investigators expect a significantly larger decrease in depressive symptoms in intervention groups than in wait-list controls over the course of the three time points.
|
From baseline to post-treatment (9 weeks later) and to 3-month follow-up
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in physiological stress levels as measured by blood pressure, skin conductance, heart rate variability measures and respiratory measures during resting state (15 minutes).
Time Frame: Baseline to post-treatment (9 weeks)
|
The investigators expect larger improvements in intervention groups than in wait-list controls.
Due to logistics, only N = 48 were tested physiologically.
|
Baseline to post-treatment (9 weeks)
|
|
Basic processes in visual attention
Time Frame: Baseline to post-treatment (9 weeks)
|
The investigators expect larger improvements in intervention groups than wait-list controls for the speed of visual processing (threshold of conscious perception measured in ms) on the Theory of Visual Attention (TVA) task developed at the Center for Visual Cognition, Copenhagen University.
The investigators expect a lowered threshold for conscious, visual perception (the TVA-t0 parameter) since they have demonstrated this effect after meditation-based training in a previous study (Jensen et al., 2012, J. Exp.
Psych.
Gen., MBSR affects Attention)
|
Baseline to post-treatment (9 weeks)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Christian G Jensen, MSc., Neurobiology Research Unit, Copenhagen University Hospital (Rigshospitalet)
- Study Director: Steen G Hasselbalch, Professor, Memory Clinic, Copenhagen University Hospital (Rigshospitalet)
- Study Chair: Gitte M Knudsen, Professor, Neurobiology Research Unit, Copenhagen University Hospital (Rigshospitalet)
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- RR-MHP-OC13
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
Ziekenhuis Oost-LimburgRecruitingQuality of Life | Postoperative Quality of Recovery | Health-Related Quality-of-LifeBelgium
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
Istituto Ortopedico RizzoliUniversity of BolognaCompletedImprove Quality of LifeItaly
-
Children's National Research InstituteCompletedProfessional Quality of LifeUnited States
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
-
University of South CarolinaNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingHealth Related Quality of LifeUnited States
-
PharmanexSprim Advanced Life SciencesCompletedHealth-related Quality of LifeUnited States
-
Region VästmanlandUnknownHealth Related Quality of Life
-
Ain Shams UniversityCompletedHealth Related Quality of LifeEgypt
Clinical Trials on Relaxation Response-based Mental Health Promotion (RR-MHP)
-
Transcultural Psychosocial Organization NepalKing's College LondonRecruitingMental Health WellnessNepal
-
Saglik Bilimleri UniversitesiNot yet recruitingQuality of Life | Type 1 Diabetes Mellitus | Diabetes Self-Management | Health Promotion Model (HPM) | Motivational Interviewing (MI)Turkey (Türkiye)
-
Mayo ClinicCompletedMalignant Solid Neoplasm | Hematopoietic and Lymphoid System Neoplasm | Obesity-Related Malignant NeoplasmUnited States